These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 918923)

  • 1. [Intravenous influsion of theophyllamine].
    Talseth T; Boye NP; Bredesen JE; Lunde PK
    Tidsskr Nor Laegeforen; 1977 Oct; 97(29):1511-13. PubMed ID: 918923
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum levels and bronchodilatation after intravenous administration of theophylline in asthmatic patients].
    Andrejak M; Lary H; Aubry P; Levi-Valensi P
    Rev Pneumol Clin; 1986; 42(2):82-6. PubMed ID: 3749701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Theophyllamine. Infusion in patients with acute severe asthma attacks and various loading doses of peroral theophylline].
    Kongerud J; Gulsvik A; Bergmann A; Calmeyer M; Haanaes OC; Selvig K; Bjerve KS
    Tidsskr Nor Laegeforen; 1985 Nov; 105(33):2377-9. PubMed ID: 4082153
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous maintenance aminophylline dosage in patients with asthma on regular oral theophylline.
    Chang KC; Chai H; Miles-Lawrence R; Bell TD; Pinney CT
    Ann Allergy; 1982 Dec; 49(6):315-7. PubMed ID: 7149347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved efficacy and safety of theophylline in the control of airways hyperreactivity.
    Hendeles L; Weinberger M
    Ann Allergy; 1982 Nov; 49(5):247-56. PubMed ID: 6128950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous intravenous therapy with theophylline in patients with brittle bronchial asthma.
    Ayres JG
    Eur Respir J; 1989 Feb; 2(2):190. PubMed ID: 2703046
    [No Abstract]   [Full Text] [Related]  

  • 7. Early estimate of theophylline clearance during intravenous infusion.
    Rizzo A; Mirabella A; Ferrara G; Mangiacavallo A; Bonanno A; Bonsignore G
    Eur J Respir Dis; 1986 Apr; 68(4):291-7. PubMed ID: 3732424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of parenteral aminophylline in patients taking slow release theophylline preparations: an observation of clinical practice.
    Arbab OA; Wiggins J; Ayres JG; Stableforth DE
    Br J Dis Chest; 1985 Apr; 79(2):161-71. PubMed ID: 3986120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transition from parenteral to oral theophylline therapy in asthmatic patients].
    Mayer L
    Fortschr Med; 1985 Oct; 103(39):923-6. PubMed ID: 4065791
    [No Abstract]   [Full Text] [Related]  

  • 10. [Monitoring of plasma theophylline levels in asthmatic patients treated with oxtriphylline].
    Morell F; Orriols R; Roca I; Fraile M; Laporte JR
    Arch Farmacol Toxicol; 1983 Apr; 9(1):89-94. PubMed ID: 6625679
    [No Abstract]   [Full Text] [Related]  

  • 11. [Individualized therapy of protracted attacks of bronchial asthma using theophylline preparations].
    Tsoĭ AN; Gavrilenko LN; Bogovskiĭ VP; Semenova LG; Antonovskiĭ IuA
    Sov Med; 1990; (6):77-81. PubMed ID: 2396131
    [No Abstract]   [Full Text] [Related]  

  • 12. [Retard theophylline in the treatment of asthma].
    Suskovic S; Jurcic B; Varga T; Furlan J
    Plucne Bolesti; 1986; 38(3-4):270-2. PubMed ID: 3588750
    [No Abstract]   [Full Text] [Related]  

  • 13. Investigation of a dosage regimen for intravenous theophylline.
    Hughey MC; Yost RL; Robinson JD; Harman EM
    Drug Intell Clin Pharm; 1982 Apr; 16(4):301-5. PubMed ID: 7067620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rectal administration of theophylline in aqueous solution.
    Pedersen S; Sommer B
    Acta Paediatr Scand; 1981 Mar; 70(2):243-6. PubMed ID: 7234406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic/pharmacodynamic modeling of theophylline in patients with different degrees of airway obstruction.
    Flores-Murrieta FJ; Mercado DE; Rodríguez-Silverio J; Chapela R
    Proc West Pharmacol Soc; 1999; 42():3-4. PubMed ID: 10697671
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical evaluation of intravenous theophylline therapy in status asthmaticus].
    Noguchi M; Yoshimura K; Nakatani T; Nakamori Y; Chonabayashi N; Nakata K; Tanimoto H; Murakawa K
    Arerugi; 1988 Nov; 37(11):1084-93. PubMed ID: 3240100
    [No Abstract]   [Full Text] [Related]  

  • 17. [Xanthines in bronchial asthma].
    Zarudiĭ FS
    Farmakol Toksikol; 1985; 48(5):105-8. PubMed ID: 2866976
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of circadian variation in serum theophylline levels in the sustained-release theophylline treatment of chronic asthma].
    Watanabe A; Urata C; Nomoto H; Mizobe M; Abe Y; Mano K; Miyamato Y; Sano Y
    Arerugi; 1986 Jul; 35(7):447-54. PubMed ID: 3778214
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dosage of intravenous theophyllamine].
    Hansen HM; Kampmann JP; Angelo HR; Christensen JM
    Ugeskr Laeger; 1983 Mar; 145(10):755-6. PubMed ID: 6857774
    [No Abstract]   [Full Text] [Related]  

  • 20. The efficacy of sustained release theophylline (Pro-Vent), in asthma.
    Wallis PJ; Joy M; Hughes DT; Empey DW
    Br J Clin Pract; 1985 Sep; 39(9):341-5. PubMed ID: 3904796
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.